What I Told Congress About Patient Access To Experimental Medicines

I recently testified at a hearing on “Examining Patient Access to Investigational Drugs,” where I used my time before legislators to tell them what I have learned after more than three years of intensive study about patient access to experimental medicines.

Source: Forbes.com Healthcare News - October 17, 2017 Category: Pharmaceuticals Authors: Alison Bateman-House, Contributor Source Type: news